APA

Boyce M., Warrington S., Cortezi B., Zöllner S., Vauléon S., Swinkels D. W., Summo L., Schwoebel F. & Riecke K. (20171017). Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects. : British journal of pharmacology.

Chicago

Boyce M, Warrington S, Cortezi B, Zöllner S, Vauléon S, Swinkels D W, Summo L, Schwoebel F and Riecke K. 20171017. Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects. : British journal of pharmacology.

Harvard

Boyce M., Warrington S., Cortezi B., Zöllner S., Vauléon S., Swinkels D. W., Summo L., Schwoebel F. and Riecke K. (20171017). Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects. : British journal of pharmacology.

MLA

Boyce M, Warrington S, Cortezi B, Zöllner S, Vauléon S, Swinkels D W, Summo L, Schwoebel F and Riecke K. Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects. : British journal of pharmacology. 20171017.